QFCUH picture
FRNLEN

>>Overview of scientific publications : Dr Christine DEVALCK

Christine DEVALCK

1: Bisogno G, Jenney M, Bergeron C, Melcón SG, Ferrari A, Oberlin O, Carli M, Stevens M, Kelsey A, Paoli A, Gaze MN, Martelli H, Devalck C, Merks JH, Ben-Arush M, Glosli H, Chisholm J, Orbach D, Minard-Colin V, De Salvo GL; European paediatric Soft tissue sarcoma Study Group. Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial. Lancet Oncol. 2018 Jun 22. pii: S1470-2045(18)30337-1. doi: 10.1016/S1470-2045(18)30337-1. [Epub ahead of print]
>PubMed

2: Dedeken L, Lê PQ, Rozen L, El Kenz H, Huybrechts S, Devalck C, Diallo S, Heijmans C, Ferster A. Automated RBC exchange compared to manual exchange transfusion for children with sickle cell disease is cost-effective and reduces iron overload. Transfusion. 2018 Jun;58(6):1356-1362. doi: 10.1111/trf.14575. Epub 2018 Mar 25.
>PubMed

3: Ronceray L, Abla O, Barzilai-Birenboim S, Bomken S, Chiang AK, Jazbec J, Kabickova E, Lazic J, Beishuizen A, Mellgren K, Tanaka F, Pillon M, Devalck C, Gouttenoire M, Makarova O, Burkhardt B, Attarbaschi A; European Intergroup for Childhood Non-Hodgkin Lymphoma (EICNHL) and the International Berlin-Frankfurt-Münster (i-BFM) Study Group. Children and adolescents with marginal zone lymphoma have an excellent prognosis with limited chemotherapy or a watch-and-wait strategy after complete resection. Pediatr Blood Cancer. 2018 Apr;65(4). doi: 10.1002/pbc.26932. Epub 2017 Dec 29.
>PubMed

4: Vaarwerk B, van der Lee JH, Breunis WB, Orbach D, Chisholm JC, Cozic N, Jenney M, van Rijn RR, McHugh K, Gallego S, Glosli H, Devalck C, Gaze MN, Kelsey A, Bergeron C, Stevens MCG, Oberlin O, Minard-Colin V, Merks JHM. Prognostic relevance of early radiologic response to induction chemotherapy in pediatric rhabdomyosarcoma: A report from the International Society of Pediatric Oncology Malignant Mesenchymal Tumor 95 study. Cancer. 2018 Mar 1;124(5):1016-1024. doi: 10.1002/cncr.31157. Epub 2017 Dec 6.
>PubMed

5: Lê PQ, Ferster A, Dedeken L, Vermylen C, Vanderfaeillie A, Rozen L, Heijmans C, Huybrechts S, Devalck C, Cotton F, Ketelslegers O, Dresse MF, Fils JF, Gulbis B. Neonatal screening improves sickle cell disease clinical outcome in Belgium. J Med Screen. 2018 Jun;25(2):57-63. doi: 10.1177/0969141317701166. Epub 2017 Jul 7.
>PubMed

6: Rogers T, Minard-Colin V, Cozic N, Jenney M, Merks JHM, Gallego S, Devalck C, Gaze MN, Kelsey A, Oberlin O, Stevens M, Spicer RD, Bergeron C, Martelli H. Paratesticular rhabdomyosarcoma in children and adolescents-Outcome and patterns of relapse when utilizing a nonsurgical strategy for lymph node staging: Report from the International Society of Paediatric Oncology (SIOP) Malignant Mesenchymal Tumour 89 and 95 studies. Pediatr Blood Cancer. 2017 Sep;64(9). doi: 10.1002/pbc.26486. Epub 2017 Feb 16.
>PubMed

7: Orbach D, Mosseri V, Gallego S, Kelsey A, Devalck C, Brenann B, van Noesel MM, Bergeron C, Merks JH, Rechnitzer C, Jenney M, Minard-Colin V, Stevens M. Nonparameningeal head and neck rhabdomyosarcoma in children and adolescents: Lessons from the consecutive International Society of Pediatric Oncology Malignant Mesenchymal Tumor studies. Head Neck. 2017 Jan;39(1):24-31. doi: 10.1002/hed.24547. Epub 2016 Jul 26.
>PubMed

8: Lê PQ, Gulbis B, Dedeken L, Dupont S, Vanderfaeillie A, Heijmans C, Huybrechts S, Devalck C, Efira A, Dresse MF, Rozen L, Benghiat FS, Ferster A. Survival among children and adults with sickle cell disease in Belgium: Benefit from hydroxyurea treatment. Pediatr Blood Cancer. 2015 Nov;62(11):1956-61. doi: 10.1002/pbc.25608. Epub 2015 Jul 14.
>PubMed

9: Sauvage D, Roufosse F, Sanoussi I, Massin M, Rooze S, De Ville A, Azzi N, Huybrechts S, Dedeken L, Devalck C, Ferster A. Treatment-refractory hypereosinophilic syndrome responding to fludarabine in a 12-year-old boy. Leuk Lymphoma. 2015;56(9):2711-3. doi: 10.3109/10428194.2014.1003058. Epub 2015 Feb 25.
>PubMed

10: Aloni MN, Lecerf P, Lê PQ, Heijmans C, Huybrechts S, Devalck C, Azzi N, Ngalula-Mujinga M, Ferster A. Is Pica under-reported in children with sickle cell disease? A pilot study in a Belgian cohort. Hematology. 2015 Aug;20(7):429-32. doi: 10.1179/1607845414Y.0000000219. Epub 2014 Dec 10.
>PubMed

11: Dedeken L, Chapusette R, Lê PQ, Heijmans C, Devalck C, Huybrechts S, Ziereisen F, Hanssens L, Rozen L, Noubouossie D, Mujinga MN, Ferster A. Reduction of the six-minute walk distance in children with sickle cell disease is correlated with silent infarct: results from a cross-sectional evaluation in a single center in Belgium. PLoS One. 2014 Oct 2;9(9):e108922. doi: 10.1371/journal.pone.0108922. eCollection 2014.
>PubMed

12: Aloni MN, Lê PQ, Heijmans C, Huybrechts S, Devalck C, Azzi N, Ngalula-Mujinga M, Ferster A. A pilot study of manual chronic partial exchange transfusion in children with sickle disease. Hematology. 2015 Jun;20(5):284-8. doi: 10.1179/1607845414Y.0000000191. Epub 2014 Aug 18.
>PubMed

13: Dedeken L, Lê PQ, Azzi N, Brachet C, Heijmans C, Huybrechts S, Devalck C, Rozen L, Ngalula M, Ferster A. Haematopoietic stem cell transplantation for severe sickle cell disease in childhood: a single centre experience of 50 patients. Br J Haematol. 2014 May;165(3):402-8. doi: 10.1111/bjh.12737. Epub 2014 Jan 16.
>PubMed

14: Kumps C, Fieuw A, Mestdagh P, Menten B, Lefever S, Pattyn F, De Brouwer S, Sante T, Schulte JH, Schramm A, Van Roy N, Van Maerken T, Noguera R, Combaret V, Devalck C, Westermann F, Laureys G, Eggert A, Vandesompele J, De Preter K, Speleman F. Focal DNA copy number changes in neuroblastoma target MYCN regulated genes. PLoS One. 2013;8(1):e52321. doi: 10.1371/journal.pone.0052321. Epub 2013 Jan 4.
>PubMed

15: Bertholdt S, Lê PQ, Heijmans C, Huybrechts S, Dedeken L, Devalck C, Schifflers S, Ferster A. [Respiratory complications of sickle cell anemia in children: the acute chest syndrome]. Rev Med Brux. 2012 May-Jun;33(3):138-44. French.
>PubMed

16: Michels E, Vandesompele J, De Preter K, Hoebeeck J, Vermeulen J, Schramm A, Molenaar JJ, Menten B, Marques B, Stallings RL, Combaret V, Devalck C, De Paepe A, Versteeg R, Eggert A, Laureys G, Van Roy N, Speleman F. ArrayCGH-based classification of neuroblastoma into genomic subgroups. Genes Chromosomes Cancer. 2007 Dec;46(12):1098-108.
>PubMed

17: Brachet C, Heinrichs C, Tenoutasse S, Devalck C, Azzi N, Ferster A. Children with sickle cell disease: growth and gonadal function after hematopoietic stem cell transplantation. J Pediatr Hematol Oncol. 2007 Jul;29(7):445-50.
>PubMed

18: Dargent JL, Devalck C, De Mey A, Vandeweyer E, Lespagnard L, Heimann P. Primary cutaneous marginal zone B-cell lymphoma of MALT type in a child. Pediatr Dev Pathol. 2006 Nov-Dec;9(6):468-73.
>PubMed

19: Gulbis B, Haberman D, Dufour D, Christophe C, Vermylen C, Kagambega F, Corazza F, Devalck C, Dresse MF, Hunninck K, Klein A, Le PQ, Loop M, Maes P, Philippet P, Sariban E, Van Geet C, Ferster A. Hydroxyurea for sickle cell disease in children and for prevention of cerebrovascular events: the Belgian experience. Blood. 2005 Apr 1;105(7):2685-90. Epub 2004 Dec 16.
>PubMed

20: Dan B, Bouillot E, Mewasingh LD, Devalck C, Bengoetxea A, Christophe C, Chéron G. Gait control in spinal palsy. Brain Dev. 2004 Oct;26(7):463-8.
>PubMed

21: Brachet C, Azzi N, Demulder A, Devalck C, Gourdin A, Gulbis B, Klein A, Le PQ, Loop M, Sariban E, Ferster A. Hydroxyurea treatment for sickle cell disease: impact on haematopoietic stem cell transplantation's outcome. Bone Marrow Transplant. 2004 Apr;33(8):799-803.
>PubMed

22: Ferster A, Tahriri P, Vermylen C, Sturbois G, Corazza F, Fondu P, Devalck C, Dresse MF, Feremans W, Hunninck K, Toppet M, Philippet P, Van Geet C, Sariban E. Five years of experience with hydroxyurea in children and young adults with sickle cell disease. Blood. 2001 Jun 1;97(11):3628-32.
>PubMed

23: De Moerloose B, Dhooge C, Laureys G, Benoit Y, Demarche M, Devalck C, Plantaz D, Leroy J, Philippé J. Discrepant flow cytometric expression and function of P-glycoprotein in neuroblastic tumors. Cytometry. 1999 Oct 1;37(2):125-32.
>PubMed

24: Lejeune M, Cantinieaux B, Harag S, Ferster A, Devalck C, Sariban E. Defective functional activity and accelerated apoptosis in neutrophils from children with cancer are differentially corrected by granulocyte and granulocyte-macrophage colony stimulating factors in vitro. Br J Haematol. 1999 Sep;106(3):756-61.
>PubMed

25: Heimann P, Devalck C, Debusscher C, Sariban E, Vamos E. Alveolar soft-part sarcoma: further evidence by FISH for the involvement of chromosome band 17q25. Genes Chromosomes Cancer. 1998 Oct;23(2):194-7.
>PubMed

26: Vandesompele J, Van Roy N, Van Gele M, Laureys G, Ambros P, Heimann P, Devalck C, Schuuring E, Brock P, Otten J, Gyselinck J, De Paepe A, Speleman F. Genetic heterogeneity of neuroblastoma studied by comparative genomic hybridization. Genes Chromosomes Cancer. 1998 Oct;23(2):141-52.
>PubMed

27: Corazza F, Beguin Y, Bergmann P, André M, Ferster A, Devalck C, Fondu P, Buyse M, Sariban E. Anemia in children with cancer is associated with decreased erythropoietic activity and not with inadequate erythropoietin production. Blood. 1998 Sep 1;92(5):1793-8.
>PubMed

28: Vertongen P, De Clerck P, Fournet JC, Martelli H, Hélardot P, Devalck C, Peeters T, Sariban E, Robberecht P. Comparison between vasoactive intestinal polypeptide and pituitary adenylate cyclase activating polypeptide levels in neuroblastoma tumour tissues. Neuropeptides. 1997 Oct;31(5):409-13.
>PubMed

29: Lejeune M, Sariban E, Cantinieaux B, Ferster A, Devalck C, Fondu P. Defective polymorphonuclear leukocyte functions in children receiving chemotherapy for cancer are partially restored by recombinant human granulocyte colony-stimulating factor in vitro. J Infect Dis. 1996 Oct;174(4):800-5.
>PubMed

30: Ferster A, Vermylen C, Cornu G, Buyse M, Corazza F, Devalck C, Fondu P, Toppet M, Sariban E. Hydroxyurea for treatment of severe sickle cell anemia: a pediatric clinical trial. Blood. 1996 Sep 15;88(6):1960-4.
>PubMed

31: de Laet C, Casimir G, Duchâteau J, Vamos E, Devalck C, Sariban E, Ferster A. [Leukemia lymphoma T-cell as first manifestation of ataxia-telangiectasia]. Arch Pediatr. 1996 Jul;3(7):681-4. French.
>PubMed

32: Lejeune M, Sariban E, Cantinieaux B, Ferster A, Devalck C, Fondu P. Granulocyte functions in children with cancer are differentially sensitive to the toxic effect of chemotherapy. Pediatr Res. 1996 May;39(5):835-42.
>PubMed

33: Vertongen P, Devalck C, Sariban E, De Laet MH, Martelli H, Paraf F, Hélardot P, Robberecht P. Pituitary adenylate cyclase activating peptide and its receptors are expressed in human neuroblastomas. J Cell Physiol. 1996 Apr;167(1):36-46.
>PubMed

34: Ferster A, Corazza F, Vertongen F, Bujan W, Devalck C, Fondu P, Cochaux P, Lambermont M, Khaladji Z, Sariban E. Transplanted sickle-cell disease patients with autologous bone marrow recovery after graft failure develop increased levels of fetal haemoglobin which corrects disease severity. Br J Haematol. 1995 Aug;90(4):804-8.
>PubMed

35: Hanquinet S, Wouters M, Devalck C, Perlmutter N, Sariban E. Increased renal parenchymal echogenicity in ifosfamide-induced renal Fanconi syndrome. Med Pediatr Oncol. 1995 Feb;24(2):116-8.
>PubMed

36: Ben Salah H, Crockaert F, Levy J, Ferster A, Devalck C, Sariban E. [Stomatococcus mucilaginosus meningitis in immunocompromised child]. Arch Pediatr. 1994 Sep;1(9):813-5. French.
>PubMed

37: Ferster A, Bujan W, Mouraux T, Devalck C, Heimann P, Sariban E. Complete remission following donor leukocyte infusion in ALL relapsing after haploidentical bone marrow transplantation. Bone Marrow Transplant. 1994 Aug;14(2):331-2.
>PubMed

38: Devalck C, Tempels D, Ferster A, De Laet MH, Bujan W, Heiman P, Sariban E. Long-term disease-free survival in a child with refractory metastatic malignant germ cell tumor treated by high-dose chemotherapy with autologous bone marrow rescues. Med Pediatr Oncol. 1994;22(3):208-10.
>PubMed

39: Ferster A, Corazza F, Heimann P, Dehou MF, De Busscher C, Devalck C, Sariban E, Vamos E. Anaplastic large cell lymphoma of true histiocytic origin in an infant: unusual clinical, hematological, and cytogenetic features. Med Pediatr Oncol. 1994;22(2):147-52.
>PubMed

40: Ouchiha M, Ferster A, Heiman P, Bujan W, Perlmutter N, Devalck C, Sariban E. [Granulocytic sarcoma with mediastinal involvement]. Arch Fr Pediatr. 1993 Nov;50(9):775-8. French.
>PubMed

41: Ferster A, Bujan W, Corazza F, Devalck C, Fondu P, Toppet M, Verhas M, Sariban E. Bone marrow transplantation corrects the splenic reticuloendothelial dysfunction in sickle cell anemia. Blood. 1993 Feb 15;81(4):1102-5.
>PubMed

42: Bujan W, Ferster A, Devalck C, Vamos E, Mascart F, Denis R, Azzi N, Vergauwen P, Sariban E. [Bone marrow graft in hereditary diseases]. Rev Med Brux. 1992 Jun;13(6):207-11. French.
>PubMed

43: Ferster A, Azzi N, Bujan W, Devalck C, Fondu P, Nafa S, Toppet M, Sariban E. [Indications for bone marrow graft in severe hemoglobinopathies]. Rev Med Brux. 1992 Jun;13(6):213-7. French.
>PubMed

44: Devalck C, Ferster A, De Laet MH, Nafa S, Bujan W, Azzi N, Ben Salah H, Corrazza F, Vergauwen P, Sariban E. [Autologous bone marrow graft in solid tumors in childhood]. Rev Med Brux. 1992 Jun;13(6):201-6. Review. French.
>PubMed

45: Bujan W, Ferster A, Azzi N, Devalck C, Leriche A, Sariban E. Use of recombinant human granulocyte colony stimulating factor in reticular dysgenesis. Br J Haematol. 1992 May;81(1):128-30.
>PubMed

!Data extracted directly from PubMed and filtered to reduce the risk of homonymy. You can remove the "QFCUH" filter to enlarge results.

>>More about Dr Christine DEVALCK.